Pretty straight forward here, since its inception has followed this same pattern. No position yet, waiting for a clear failure of the top red channel for short term short position. Break here and verify support will take swing position with a 20-25 target.
If fail in red channel, short target is $8, but wouldn't doubt revisiting 3's again in the event of market dump.
First time in companies history that they are making any meaningful revenue off approved drug. Factor D is big picture here. not to be the guy that says this time is different but I think this time is different. still think MC is getting ahead of itself so do see a pullback but not to 8.